Cobus Loots, CEO of Pan African Resources, on delivering sector-leading returns for shareholders. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksXaar Regulatory News (XAR)

Share Price Information for Xaar (XAR)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 124.00
Bid: 0.00
Ask: 0.00
Change: 0.00 (0.00%)
Spread: 3.50 (2.905%)
Open: 0.00
High: 0.00
Low: 0.00
Prev. Close: 124.00
XAR Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Trading Statement-COVID-19 & Preliminary Statement

23 Mar 2020 17:47

RNS Number : 2844H
Xaar PLC
23 March 2020
 

Xaar plc

 

Trading update and revised date for full year results 

 

Xaar plc ("Xaar" or the "Group"), the leading inkjet printing technology Group, announces a confirmation of previous guidance and a revised date for the presentation of full year results.

 

Full year results

 

Preliminary financial statements for the 12 months ended 31 December 2019 were scheduled to be released 24 March 2020.

 

The FCA has strongly requested all listed companies observe a moratorium on the publication of preliminary financial statements for at least two weeks.

 

In compliance with this request, Xaar will not be releasing preliminary financial statements, but will publish full audited financial statements within four months of the financial year end, subject to any further guidance from the FCA.

 

Trading update

 

Xaar continues to make good progress with its strategy and re-iterates the preliminary guidance for 2019:

 

The Group expects to report revenues for its continuing operations of £49.4 million for the year ended 31 December 2019.

 

Group cash balances (including cash held for investment in Xaar 3D) were £25.3 million at 31 December 2019.

 

COVID19 - Update

 

The health, safety and security of our employees is our upmost priority and appropriate actions have been taken to our operational procedures to mitigate risk.

 

The Group's trading performance in 2020 to date has been in line with expectations. No orders have been cancelled, however we are mindful of the rapidly changing environment in which the business is operating.

 

While the full implications of COVID-19 on the financial performance for the current financial year are difficult to determine at this stage, the Board remains confident in the long-term prospects of the Group.

 

 

Enquiries:

Xaar plc

+44 (0)1223 423 663 

John Mills, Chief Executive Officer

Ian Tichias, Chief Finance Officer

 

 

Tulchan Communications

+44 (0)20 7353 4200

James Macey White

Giles Kernick

Hollie Ralston

 

About XaarXaar is a world leader in the development of digital inkjet technology. Our technology drives the conversion of analogue printing and manufacturing methods to digital inkjet which is more efficient, more economical and more productive than the traditional methods which have been in use for years. We design and manufacture printheads as well as systems for product decoration and industrial 3D Printing which use our inkjet technology. We are the only truly independent inkjet technology company with over 25 years of know how. We offer unrivalled inkjet expertise including technology and printhead design and development and manufacture highly customised product decoration systems and industrial 3D Printing for volume manufacturing. Our unique technologies and products are the leading enabler for innovation and for driving supply chain efficiencies for many industries. Information about Xaar is at www.xaar.com

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
TSTPPUQCWUPUGMW
Date   Source Headline
19th Feb 20109:00 amRNSHolding(s) in Company
21st Jan 20107:00 amRNSPeriod end trading update
26th Oct 200910:42 amRNSHolding(s) in Company
14th Oct 20097:00 amRNSInterim Management Statement
16th Sep 20093:19 pmRNSHolding(s) in Company
10th Sep 200911:18 amRNSHolding(s) in Company
2nd Sep 20099:59 amRNSHolding(s) in Company
19th Aug 20097:00 amRNSHalf Yearly Report & Results
11th Aug 20097:00 amRNSNotice of Half Yearly Report
15th Jul 20097:00 amRNSHalf year period-end trading update
5th Jun 20091:22 pmRNSHolding(s) in Company
2nd Jun 200911:26 amRNSHolding(s) in Company
2nd Jun 200911:24 amRNSHolding(s) in Company
5th May 20095:04 pmRNSHolding(s) in Company
29th Apr 20092:06 pmRNSResult of AGM
16th Apr 20093:23 pmRNSGrant of Options
16th Apr 20097:00 amRNSAnnual Information Update
16th Apr 20097:00 amRNSInterim Management Statement
8th Apr 20099:35 amRNSChange of Adviser
7th Apr 20094:47 pmRNSDirector/PDMR Shareholding
3rd Apr 20093:38 pmRNSDirector/PDMR Shareholding
1st Apr 20094:04 pmRNSDirector/PDMR Shareholding
1st Apr 20097:00 amRNSManufacturing rationalisation
26th Mar 20095:21 pmRNSDirector/PDMR Shareholding
25th Mar 200910:38 amRNSDirector/PDMR Shareholding
23rd Mar 20097:00 amRNSFinal Results
13th Mar 20094:40 pmRNSSecond Price Monitoring Extn
13th Mar 20094:35 pmRNSPrice Monitoring Extension
6th Mar 20099:00 amRNSHolding(s) in Company
4th Mar 20097:00 amRNSNotice of Final Results
24th Feb 20097:00 amRNSNew product launch
18th Feb 200912:15 pmRNSDirector/PDMR Shareholding
16th Jan 20093:45 pmRNSHolding(s) in Company
15th Jan 20097:00 amRNSFull Year Trading Update
14th Jan 20093:00 pmRNSHolding(s) in Company
7th Jan 20094:15 pmRNSHolding(s) in Company
7th Jan 20099:00 amRNSHolding(s) in Company
23rd Dec 20083:57 pmRNSHolding(s) in Company
16th Dec 20084:40 pmRNSSecond Price Monitoring Extn
16th Dec 20084:35 pmRNSPrice Monitoring Extension
1st Dec 20083:10 pmRNSDirector/PDMR Shareholding
28th Nov 20089:00 amRNSDirector/PDMR Shareholding
26th Nov 20087:00 amRNSTrading Update
24th Nov 20084:40 pmRNSPrice Monitoring Extension
12th Nov 20084:05 pmRNSDirector/PDMR Shareholding Replacement
12th Nov 20083:03 pmRNSDirector/PDMR Shareholding
21st Oct 20089:00 amRNSHolding(s) in Company
15th Oct 20087:00 amRNSInterim Management Statement
13th Oct 20084:41 pmRNSSecond Price Monitoring Extn
13th Oct 20084:36 pmRNSPrice Monitoring Extension

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.